Journal Article

Transmissibility and potential for disease progression of drug resistant Mycobacterium tuberculosis: prospective cohort study

Bayona, Jaime, Galea, Jerome, Calderon, Roger, Yataco, Rosa, Huang, Chuan-Chin, Becerra, Mercedes C, Farmer, Paul, Murray, Megan, Contreras, Carmen, Zhang, Zibiao, Atwood, Sidney, Mitnick, Carole D, Lecca, Leonid, Cohen, Ted

2019

Overview

AbstractObjectiveTo measure the association between phenotypic drug resistance and the risk of tuberculosis infection and disease among household contacts of patients with pulmonary tuberculosis.Setting106 district health centers in Lima, Peru between September 2009 and September 2012.DesignProspective cohort study.Participants10 160 household contacts of 3339 index patients with tuberculosis were classified on the basis of the drug resistance profile of the patient: 6189 were exposed to drug susceptible strains of Mycobacterium tuberculosis, 1659 to strains resistant to isoniazid or rifampicin, and 1541 to strains that were multidrug resistant (resistant to isoniazid and rifampicin).Main outcome measuresTuberculosis infection (positive tuberculin skin test) and the incidence of active disease (diagnosed by positive sputum smear or chest radiograph) after 12 months of follow-up.ResultsHousehold contacts exposed to patients with multidrug resistant tuberculosis had an 8% (95% confidence interval 4% to 13%) higher risk of infection by the end of follow-up compared with household contacts of patients with drug sensitive tuberculosis. The relative hazard of incident tuberculosis disease did not differ among household contacts exposed to multidrug resistant tuberculosis and those exposed to drug sensitive tuberculosis (adjusted hazard ratio 1.28, 95% confidence interval 0.9 to 1.83).ConclusionHousehold contacts of patients with multidrug resistant tuberculosis were at higher risk of tuberculosis infection than contacts exposed to drug sensitive tuberculosis. The risk of developing tuberculosis disease did not differ among contacts in both groups. The evidence invites guideline producers to take action by targeting drug resistant and drug sensitive tuberculosis, such as early detection and effective treatment of infection and disease.Trial registrationClinicalTrials.gov NCT00676754.

• Publisher: BMJ Publishing Group LTD,BMJ Publishing Group Ltd
• Subject: Cohort analysis / Drug resistance / Epidemiology / Households / Isoniazid / Multidrug resistance / Mycobacterium tuberculosis / Rifampin / Skin tests / Sputum / Tuberculin / Tuberculosis